Sarasa Kim, MD
Clinical Fellow
Radiology
School of Medicine

Publications (3)

Top publication keywords:
MelanomaCasein Kinase IIMitogen-Activated Protein KinasesMutationRNA, MessengerProteomicsPhosphatidylinositol 3-KinasePhosphopeptidesMembrane ProteinsSignal TransductionProto-Oncogene Proteins c-aktMelanocytesGTP PhosphohydrolasesMass SpectrometrySkin Neoplasms

• Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2024 Tuchayi AM, Yadav S, Jiang F, Kim ST, Saelee RK, Morley A, Juarez R, Lawhn-Heath C, Wang Y, de Kouchkovsky I, Hope TA
• MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas.
  Oncotarget 2018 Posch C, Sanlorenzo M, Ma J, Kim ST, Zekhtser M, Ortiz-Urda S
• Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells.
  The Journal of investigative dermatology 2016 Posch C, Sanlorenzo M, Vujic I, Oses-Prieto JA, Cholewa BD, Kim ST, Ma J, Lai K, Zekhtser M, Esteve-Puig R, Green G, Chand S, Burlingame AL, Panzer-Grümayer R, Rappersberger K, Ortiz-Urda S